ES551058A0 - Procedimiento de preparar nuevos derivados morfolinicos - Google Patents

Procedimiento de preparar nuevos derivados morfolinicos

Info

Publication number
ES551058A0
ES551058A0 ES551058A ES551058A ES551058A0 ES 551058 A0 ES551058 A0 ES 551058A0 ES 551058 A ES551058 A ES 551058A ES 551058 A ES551058 A ES 551058A ES 551058 A0 ES551058 A0 ES 551058A0
Authority
ES
Spain
Prior art keywords
procedure
morpholine derivatives
preparing new
new morpholine
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES551058A
Other languages
English (en)
Other versions
ES8705405A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Publication of ES8705405A1 publication Critical patent/ES8705405A1/es
Publication of ES551058A0 publication Critical patent/ES551058A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES551058A 1984-12-20 1985-12-20 Procedimiento de preparar nuevos derivados morfolinicos Expired ES8705405A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8419553A FR2575158B1 (fr) 1984-12-20 1984-12-20 Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central

Publications (2)

Publication Number Publication Date
ES8705405A1 ES8705405A1 (es) 1987-05-16
ES551058A0 true ES551058A0 (es) 1987-05-16

Family

ID=9310832

Family Applications (1)

Application Number Title Priority Date Filing Date
ES551058A Expired ES8705405A1 (es) 1984-12-20 1985-12-20 Procedimiento de preparar nuevos derivados morfolinicos

Country Status (6)

Country Link
US (1) US4605654A (es)
EP (1) EP0187096A1 (es)
JP (1) JPS61158971A (es)
ES (1) ES8705405A1 (es)
FR (1) FR2575158B1 (es)
ZA (1) ZA859695B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ284687B6 (cs) * 1986-04-30 1999-02-17 Dainippon Pharmaceutical Co., Ltd. Substituovaný benzamidový derivát, způsob jeho výroby a farmaceutický prostředek na jeho bázi
US7294637B2 (en) * 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
EP1318988A2 (en) * 2000-09-11 2003-06-18 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
US6871366B2 (en) * 2002-06-26 2005-03-29 Mu-Hyun Cho Mattress-integral stone bed
NZ598165A (en) 2009-07-31 2013-05-31 Global Alliance For Tb Drug Dev Nitroimidazooxazine and nitroimidazooxazole analogues and their uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1138405A (en) * 1966-12-28 1969-01-01 Ici Ltd Morpholine derivatives
GB1260886A (en) * 1969-06-20 1972-01-19 Ici Ltd Process for aryloxymethylmorpholine derivatives
DE2728898A1 (de) * 1977-06-27 1979-01-18 Thomae Gmbh Dr K Neue morpholinderivate
FR2479814A1 (fr) * 1980-04-04 1981-10-09 Fabre Sa Pierre Phenyl alcoxy propanolamines, leur preparation et leur application en tant que medicaments

Also Published As

Publication number Publication date
US4605654A (en) 1986-08-12
JPS61158971A (ja) 1986-07-18
ZA859695B (en) 1986-08-27
ES8705405A1 (es) 1987-05-16
FR2575158A1 (fr) 1986-06-27
EP0187096A1 (fr) 1986-07-09
FR2575158B1 (fr) 1987-10-02

Similar Documents

Publication Publication Date Title
NO850300L (no) Fremgangsmaate for fremstilling av 3-imidazolylmetyl-tetrahydrokarbazolon-derivater
MX159807A (es) Procedimiento para preparar derivados de bencimidazol
ES543186A0 (es) Procedimiento para preparar nuevos derivados de aminotetra- lina
ES540464A0 (es) Procedimiento para preparar derivados de pleuromutilina
ES547863A0 (es) Procedimiento para preparar derivados de piperidina
ES544400A0 (es) Procedimiento de preparar derivados aminicos
ES546189A0 (es) Procedimiento de obtencion de derivados de 4-aril-1,4-dihi- dropiridinas
ES547468A0 (es) Procedimiento de preparacion de derivados aminometilfosfoni-cos
MX161397A (es) Procedimiento para preparar derivados de 1,3 oxazolidin-2-ona
MX159654A (es) Procedimiento para preparar derivados de hidroxi-4-2h-1-benzotiopiran-2-onas
ES550960A0 (es) Procedimiento para preparar derivados azolialquilicos
NO851550L (no) Fremgangsmaate for fremstilling av imidazolderivater
ES547411A0 (es) Procedimiento de preparar compuestos triaminobencenicos yo- dados
ES542469A0 (es) Procedimiento de preparar derivados iminotiazolidinicos
ES543985A0 (es) Procedimiento para preparar derivados de butiramida
ES555459A0 (es) Procedimiento para preparar derivados de saframicina a.
ES549076A0 (es) Procedimiento para preparar derivados de fenilpiperazina
ES539074A0 (es) Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos.
IT8505129A1 (it) Procedimento per preparare 3-esometilenecefam derivati
ES557069A0 (es) Procedimiento para preparar derivados de benzazol
ES557171A0 (es) Procedimiento para preparar derivados de isoquinolinona
ES541140A0 (es) Procedimiento para preparar derivados carboxialquildipepti- dicos
ES543014A0 (es) Procedimiento para preparar nuevos derivados de quinoleina
ES546140A0 (es) Procedimiento de preparar aminolactonas
ES535998A0 (es) Procedimiento de preparar derivados triazolicos